INTRODUCTION AND OBJECTIVES:
Cytoreductive nephrectomy (CN) for metastatic renal cell cancer (mRCC) with tumor thrombus is complex and pre-surgical targeted therapy may be used in selected patients who have a very limited life expectancy. The purpose of this study was to evaluate overall survival (OS) for mRCC patients with thrombus treated with presurgical therapy prior to CN compared to upfront cytoreductive surgery. . METHODS: Comprehensive data was reviewed for 486 mRCC patients with tumor thrombus treated surgically between 2000 to 2015 at six centers. Patients were divided into two groups: PSCN, (pre-surgical therapy þCN; N¼39); upfront CN (n¼447).Patients were stratified using IMDC criteria into risk groups (61 patients excluded for missing data) and OS compared using the Kaplan Meier method.
RESULTS: Thrombus level (Neves) was 0,1,2,3, and 4 in 131(29.3%), 59(13.1%),154(34.4%), 61(13.6%) and 42 (9.4%) in upfront CN patients and 13 (13.3%),10 (25.6%), 9 (23.1%), 5(12.8%) and 2 (5.1%) in PSCN patients. 
Positive nodal status and the number of positive nodes are well known independent predictors of survival in renal clear cell carcinoma (ccRCC) patients. However, no study has ever tested whether the location of nodal metastases does affect cancer specific survival (CSS) in ccRCC patients.
METHODS: Among 2,884 patients treated with nephrectomy at two European Tertiary Care Centers, 419 (14.4%) underwent open extended retroperitoneal lymph node dissection (LND) defined as the removal of hilar, side-specific (paraaortic or pre-retrocaval) and interaortocaval nodes. Cox regression analyses were used to assess the effect of the area involved (hilar vs. side-specific vs. interaortocaval) and the number of anatomical areas affected by nodal disease (1 vs. 2 vs. 3 areas) on CSS. Multivariable analyses were adjusted for age, pathologic T stage, metastases at diagnosis and Fuhrman grade.
RESULTS: ccRCC patients who were selected for nephrectomy and extended LND (n¼419) showed pT1-pT2 in 37.4%, pT3 in 56.1% and pT4 in 6.4% of patients. Mean tumor size was 9 cm (median 8.3, range 1-23). Overall, 95 patients (22.9%) showed nodal disease at final pathology. Mean number of nodes removed was 15 (range 3-58). Hilar nodes vs. paraaortic/precaval vs. interaortocaval were found positive in 11% vs. 18% vs. 12% of the cases, respectively. In 46 (11%), 26 (6.2%) and 23 (5.5%) cases 1, 2 or all retroperitoneal nodal areas were affected, respectively. Among patients with 1 positive nodal site, 26% of patients were positive only in the interaortocaval area and 54.3% only in side-specific station. Among patients with 2 positive nodal areas, 3.8% had hilar and interaortocaval areas involved but not side-specific one, and 53.8% had side-specific and interaortocaval areas involved but not hilar one. Mean follow up Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e63
